|
Saroja Pharma Industries India Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
17.29 Cr.
|
P/BV
|
1.18
|
Book Value (Rs.)
|
36.42
|
|
52 Week High/Low (Rs.)
|
62/34
|
FV/ML
|
10/1600
|
P/E(X)
|
16.72
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
2.57
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 38.36 | 18.72 | 19.55 | 21.12 |
| Total Income From Operations | 38.36 | 18.72 | 19.55 | 21.12 |
| | | | | |
| EXPENDITURE | | | | |
| Consumption of Raw Materials | 37.13 | 16.36 | 17.09 | 15.08 |
| Increase/Decrease in Stocks | -0.95 | 0.06 | -0.14 | 3.60 |
| Employees Cost | 0.62 | 0.59 | 0.74 | 0.72 |
| Depreciation | 0.06 | 0.05 | 0.06 | 0.04 |
| Other Expenses | 0.59 | 0.58 | 0.47 | 0.54 |
| Total Expenses | 37.45 | 17.64 | 18.23 | 19.98 |
| | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.91 | 1.08 | 1.32 | 1.14 |
| Other Income | 0.40 | 0.07 | -0.19 | 0.39 |
| P/L Before Interest, Excpt. Items & Tax | 1.31 | 1.15 | 1.13 | 1.52 |
| Interest | 0.53 | 0.69 | 0.62 | 0.83 |
| P/L Before Exceptional Items & Tax | 0.78 | 0.46 | 0.51 | 0.70 |
| P/L Before Tax | 0.78 | 0.46 | 0.51 | 0.70 |
| Tax | 0.21 | 0.13 | 0.14 | 0.19 |
| P/L After Tax from Ordinary Activities | 0.57 | 0.34 | 0.38 | 0.50 |
| Net Profit/Loss For the Period | 0.57 | 0.34 | 0.38 | 0.50 |
| | | | | |
| Equity Share Capital | 4.02 | 4.02 | 4.02 | 4.02 |
| Reserves And Surplus | 0.00 | 0.00 | 10.62 | 10.62 |
| EPS Before Extra Ordinary * | | | | |
| Basic EPS (Rs.) | 1.42 | 0.83 | 2.49 | 1.68 |
| Diluted EPS (Rs.) | 1.42 | 0.83 | 2.49 | 1.68 |
| EPS After Extra Ordinary * | | | | |
| Basic EPS (Rs.) | 1.42 | 0.83 | 2.49 | 1.68 |
| Diluted EPS (Rs.) | 1.42 | 0.83 | 2.49 | 1.68 |
| | | | | |
| PBITOE Margin (%) | 2.35 | 5.77 | 6.76 | 5.38 |
| PBTE Margin (%) | 2.04 | 2.48 | 2.61 | 3.29 |
| PBT Margin (%) | 2.04 | 2.48 | 2.61 | 3.29 |
| PAT Margin (%) | 1.48 | 1.79 | 1.92 | 2.37 |
